2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer

Details for Australian Patent Application No. 2006250809 (hide)

Owner Lorus Therapeutics Inc.

Inventors Lee, Yoon; Al-Qawasmah, Raed; Young, Aiping H.; Khine, Aye Aye; Lock, Lisa; Huesca, Mario; Wright, Jim A.

Agent Lesicar Perrin

Pub. Number AU-B-2006250809

PCT Pub. Number WO2006/126177

Priority 60/787,526 31.03.06 US; 60/710,551 22.08.05 US; 60/684,162 25.05.05 US

Filing date 25 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 12 May 2011

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/126177 Priority application(s): WO2006/126177

16 July 2009 Assignment before Grant

  GeneSense Technologies Inc. The application has been assigned to Lorus Therapeutics Inc. Assignments before Grant, Section 113

12 May 2011 Application Accepted

  Published as AU-B-2006250809

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006250828-Modulation of plant growth by altering amino acid uptake

2006250799-Pelvic clamp